Abstract
This laboratory has studies underway on the molecular characterization of the major receptors of the autonomic nervous system, as well as the slow inward calcium channel of cardiac and smooth muscle (1). The receptors under investigation include α1, α2, β1 and β2-adrenergic, muscarinic cholinergic and dopaminergic types. To date we have made substantial progress with the complete purification of α1, βl and β2 adrenergic and muscarinic cholinergic receptors and have molecular size information on α2-adrenergic and D2 dopaminergic receptors (Table I).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
J. C. Venter, C. M. Fraser, J. S. Schaber, C. Y. Jung, G. Bolger and D. Triggle, Molecular properties of the slow inward Ca channel, J. Biol. Chem. 258: 9344 (1983).
C. M. Fraser and J. C. Venter, Monoclonal antibodies to ß-adrenergic receptors: their use in purification and molecular characterization of ß-receptors, Proc. Natl. Acad. Sci. USA 77: 7034 (1980).
J. C. Venter and C. M. Fraser, The development of monoclonal antibodies to ß-adrenergic receptors and their use in receptor purification and characterization, in: “Monoclonal Antibodies in Endocrine Research,” R. E. Fellows and G. S. Eisenbarth, eds., Raven Press, New York (1981).
J. C. Venter, Monoclonal antibodies and autoantibodies in the isolation and characterization of neurotransmitter receptors: the future of receptor research, J. Molec. Cell Cardiol. 14: 687 (1982).
C. M. Fraser, R. Greguski, B. Eddy, and J. C. Venter, Autoantibodies and monoclonal antibodies in the purification and molecular characterization of neurotransmitter receptors, J. Cell. Biochem., in press.
J. C. Venter, B. Eddy, L. Hall, and C. M. Fraser, Monoclonal antibodies detect the conservation of muscarinic cholinergic receptor structure from human brain to Drosophila and possible homology with al-adrenergic receptors, Proc. Natl. Acad. Sci. USA, in press.
C. M. Fraser and J. C. Venter, The size of the mammalian lung 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography, Biochem. Biophys. Res. Commun. 109: 21 (1982).
J. C. Venter, High efficiency coupling between ß-adrenergic receptors and cardiac contractility: direct evidence for “spare” ß-adrenergic receptors, Mol. Pharmacol. 16: 429 (1979).
G. Kunos, W. H. Kan, R. Greguski, and J. C. Venter, Selective affinity labeling and molecular characterization of hepatic a -adrenergic receptors with [3H]phenoxybenzamine, J. Biol. Chem. 58: 326 (1983).
J. C. Venter, P. Horne, B. Eddy, R. Greguski, and C. M. Fraser, a -Adrenergic receptor structure, Mol. Pharmacol., submit-ted.
J. C. Venter, Muscarinic cholinergic receptor structure, J. Biol. Chem. 258: 4842 (1983).
L. Lilly, C. M. Fraser, C. Y. Jung, P. Seeman, and J. C. Venter, Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation, Mol. Pharmacol. 24: 10 (1983).
J. C. Venter, Neurotransmitter receptor structure and evolution, in: “Receptor Biochemistry and Methodology, Vol. 4,” J. C. Venter, C. M. Fraser and J. Lindstrom, eds., Allan R. Liss, Inc., New York, in press.
W. L. Strauss, G. Ghai, C. M. Fraser, and J. C. Venter, Hydrodynamic properties and sulfhydryl reagent sensitivity of ß (cardiac) and ß (lung and liver) adrenergic receptlors: Molecular evidence for isoreceptors, Fed. Proc. 38: 843 (1979).
D. R. Jeffrey, R. R. Charlton, and J. C. Venter, Reconstitution of turkey erythrocyte ß-adrenergic receptors into human erythrocyte acceptor membranes, J. Biol. Chem. 255: 5015 (1980).
J. C. Venter and C. M. Fraser, The structure of alpha and beta-adrenergic receptors, TIPS 4: 256 (1983).
J. C. Venter and C. M. Fraser, ß-Adrenergic receptor isolation and characterization with immobilized drugs and monoclonal antibodies, Fed. Proc. 42: 273 (1983).
C. M. Fraser, ß-Adrenergic receptors: Monoclonal antibodies and receptor structure, in: “Receptor Biochemistry and Methodology, Vol. 4,” J. C. Venter, C. M, Fraser, and J. Lindstrom, eds., Alan R. Liss, Inc., New York, in press.
W. L. Strauss, Molecular characterization of ß-adrenergic receptors, Doctoral dissertation, State University of New York at Buffalo (1980).
W. L. Strauss, Sulfhydryl groups and disulfide bonds: Modification of amino acid residues in studies of receptor structure and function, in: “Receptor Biochemistry and Methodology, Vol. 1,” J. C. Venter and L. C. Harrison, eds., Alan R. Liss, Inc., New York, in press.
J. C. Venter, C. M. Fraser, and L. C. Harrison, Autoantibodies to ß2-adrenergic receptors: A possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma, Science 207: 1361 (1980).
C. M. Fraser, J. C. Venter, and M. Kaliner, Autonomic abnormalities and autoantibodies to 1S-adrenergic receptors: their use in receptor purification and characterization, N. Engl. J. Med. 305: 1165 (1981).
J. C. Venter, C. M. Fraser, A. I. Soiefer, D. R. Jeffrey, W. L. Strauss, R. R. Charlton, and R. Greguski, Autoantibodies and monoclonal antibodies to I3-adrenergic receptors: their use in receptor purification and characterization, Adv. Cyclic Nucleotide Res. 14: 135 (1981).
W. Strauss, G. Ghai, C. Fraser, and J. Venter, Detergent solubilization of mammalian cardiac and hepatic ß-adrenergic receptors, Arch. Biochem. Biophys. 196: 566 (1979).
P.O. Couraud, B. Z. Lu, A. Schmutz, O. Durieu-Trautmann, C. Klutchko-Delavier, J. Hoebeke, and A. D. Strosberg, Immunological studies of (3-adrenergic receptors, J. Cell. Biochem., in press.
J. P. DeHaye, P. F. Blackmore, J. C. Venter, and J. H. Exton, Studies on the a-adrenergic activation of hepatic glucose output: a-adrenergic activation of phosphorylase by immobilized epinephrine, J. Biol. Chem. 255: 3905 (1980).
P. F. Blackmore, B. P. Hughes, R. Charest, E. A. Shuman, and J. A. Exton, Time course of al-adrenergic and vasopressin actions on phosphorylase activation, calcium efflux, pyridine nucleotide reduction, and respiration in hepatocytes, J. Biol. Chem. 258: 10488 (1983).
J. C. Venter, J. S. Schaber, D. C. U’Prichard, and C. M. Fraser, Molecular size of the human platelet a -adrenergic receptor as determined by radiation inactivation, Biochem. Biophys. Res. Comm., submitted.
T. Haga, Molecular size of muscarinic acetylcholine receptors of rat brain, FEBS Lett. 113: 68 (1980).
N. J. M. Birdsall, A. S. V. Burgen, and E. Hulme, A study of the muscarinic receptor by gel electrophoresis, Br. J. Pharmacol. 66: 337 (1979).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Venter, J.C., Fraser, C.M. (1984). The Structure and Evolution of Neurotransmitter Receptors (α- and β-Adrenergic, Dopaminergic and Muscarinic Cholinergic). In: Kito, S., Segawa, T., Kuriyama, K., Yamamura, H.I., Olsen, R.W. (eds) Neurotransmitter Receptors. Advances in Experimental Medicine and Biology, vol 175. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-4805-4_21
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4805-4_21
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-4807-8
Online ISBN: 978-1-4684-4805-4
eBook Packages: Springer Book Archive